Skip links

Δημοσιεύσεις - εργασίες σε επιστημονικά περιοδικά

  1. Effects of Darbepoetin Alfa on plasma mediators of oxidative and nitrosative stress in anemic patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.Parissis JT, Kourea K, Andreadou I, Ikonomidis I, Markantonis S, Ioannidis K, Paraskevaidis I, Iliodromitis E, Filippatos G, Kremastinos DT. Am J Cardiol. 2009 Apr 15;103(8):1134-8.
  2. Effects of darbepoetin-alpha on quality of life and emotional stress in anemic patients with chronic heart failure.Kourea K, Parissis JT, Farmakis D, Paraskevaidis I, Panou F, Filippatos G, Kremastinos DT.Eur J Cardiovasc Prev Rehabil. 2008 Jun;15(3):365-9
  3. Effects of darbepoetin alpha on right and left ventricular systolic and diastolic function in anemic patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.Parissis JT, Kourea K, Panou F, Farmakis D, Paraskevaidis I, Ikonomidis I, Filippatos G, Kremastinos DT.Am Heart J. 2008 Apr;155(4):751.e1-7.
  4. Effects of levosimendan on coronary artery flow and cardiac performance in patients with advanced heart failure.Ikonomidis I, Parissis JT, Paraskevaidis I, Kourea K, Bistola V, Lekakis J, Filippatos G, Kremastinos DT.Eur J Heart Fail. 2007 Dec;9(12):1172-7.
  5. Effects of darbepoetin-alpha on plasma pro-inflammatory cytokines, anti-inflammatory cytokine interleukin-10 and soluble Fas/Fas ligand system in anemic patients with chronic heart failure.Kourea K, Parissis JT, Farmakis D, Panou F, Paraskevaidis I, Venetsanou K, Filippatos G, Kremastinos DT.Atherosclerosis. 2008 Jul;199(1):215-21.
  6. Effect of levosimendan on ventricular arrhythmias and prognostic autonomic indexes in patients with decompensated advanced heart failure secondary to ischemic or dilated cardiomyopathy.Flevari P, Parissis JT, Leftheriotis D, Panou F, Kourea K, Kremastinos DT.Am J Cardiol. 2006 Dec 15;98(12):1641-5.
  7. Effects of levosimendan on right ventricular function in patients with advanced heart failure.Parissis JT, Paraskevaidis I, Bistola V, Farmakis D, Panou F, Kourea K, Nikolaou M, Filippatos G, Kremastinos D.Am J Cardiol. 2006 Dec 1;98(11):1489-92.
  8. Pre-treatment with Irbesartan attenuates left atrial stunning after electrical cardioversion of atrial fibrillation.Dagres N, Karatasakis G, Panou F, Athanassopoulos G, Maounis T, Tsougos E, Kourea K, Malakos I, Kremastinos DT, Cokkinos DV.Eur Heart J. 2006 Sep;27(17):2062-8.
  9. Anti-cytokine therapies in chronic heart failure: is this concept still alive?Parissis JT, Kourea K, Kremastinos D.Hellenic J Cardiol. 2005 Mar-Apr;46(2):101-7. Review.
  10. Tobacco use, exposure to secondhand smoke, and cessation counseling among health professions students: greek data from the global health professions student Survey (GHPSS). Barbouni A1, Hadjichristodoulou C, Merakou K, Antoniadou E, Kourea K, Miloni E, Warren CW, Rachiotis G, Kremastinou J. Int J Environ Res Public Health. 2012 Jan;9(1):331-42
  11. Knowledge and Perceptions about Nicotine, Nicotine Replacement Therapies and Electronic Cigarettes among Healthcare Professionals in Greece.Moysidou A, Farsalinos KE, Voudris V, Merakou K, Kourea K, Barbouni A.Int J Environ Res Public Health. 2016 May 20;13(5).
  12. Electronic Cigarette Smoking Increases Arterial Stiffness and Oxidative Stress to a Lesser Extent Than a Single Conventional Cigarette: An Acute and Chronic Study.Ikonomidis I, Vlastos D, Kourea K, Kostelli G, Varoudi M, Pavlidis G, Efentakis P, Triantafyllidi H, Parissis J, Andreadou I, Iliodromitis E, Lekakis J. Circulation. 2018 Jan 16;137(3):303-306
  13. Effects of varenicline and nicotine replacement therapy on arterial elasticity, endothelial glycocalyx and oxidative stress during a 3-month smoking cessation program. Ikonomidis I, Marinou M, Vlastos D, Kourea K, Andreadou I, Liarakos N, Triantafyllidi H, Pavlidis G, Tsougos E, Parissis J, Lekakis J. Atherosclerosis. 2017 Jul;262:123-130.
  14. Prevalence and determinants of current and secondhand smoking in Greece: results from the Global Adult Tobacco Survey (GATS) study. Rachiotis G, Barbouni A, Katsioulis A, Antoniadou E, Kostikas K, Merakou K, Kourea K, Khoury RN, Tsouros A, Kremastinou J, Hadjichristodoulou C. BMJ Open. 2017 Jan 19;7(1):e013150.